PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
128 hedge funds and large institutions have $335M invested in Progenics Pharmaceuticals Inc in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
28% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 25
Holders
128
Holding in Top 10
1
Calls
$1.01M
Puts
$1.38M
Top Buyers
| 1 | +$7.52M | |
| 2 | +$5.37M | |
| 3 | +$4.58M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.71M |
| 5 |
BlackRock
New York
|
+$2.89M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$8.98M | |
| 3 | -$6.19M | |
| 4 |
PFC
Phocas Financial Corp
Alameda,
California
|
-$5.17M |
| 5 |
RA
Royce & Associates
New York
|
-$4.93M |